Published in
Bohn Stafleu van Loghum, Critical Care, 6(15), p. 1009
DOI: 10.1186/cc10527
Links
- ORCID
- Bohn Stafleu van Loghum | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [ccforum.com] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net]
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Finding new therapies for sepsis: the need for patient stratification and the use of genetic biomarkers
Journal article published in 2011 by
Michael J. Hobson,
Hector R. Wong 
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
Abstract Reversing the immunoparalysis associated with septic shock remains a priority for improving the outcome of patients suffering from sepsis. The efficacy of future therapies may be better studied under an effective system of patient stratification. Gene expression biomarkers offer a mechanism by which patients may be appropriately stratified in such clinical trials.